ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2503

Cytokines Regulate the Fibrotic Response of Growth Factors in Joint Fibroblast-like Synoviocytes

Sofie Falkenløve Madsen1, Mikkel Rathsach Andersen2, Alexander Scheller Madrid2, Signe Holm Nielsen3, Morten Karsdal3, Christian Thudium3 and Anne-Christine Bay-Jensen3, 1University of Copenhagen, Herlev, Denmark, 2Herlev-Gentofte Hospital, Gentofte, Denmark, 3Nordic Bioscience, Herlev, Denmark

Meeting: ACR Convergence 2023

Keywords: Biomarkers, Collagen, Fibroblasts, Synovial, Osteoarthritis, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 14, 2023

Title: Abstracts: Cytokines & Cell Trafficking

Session Type: Abstract Session

Session Time: 4:00PM-5:30PM

Background/Purpose: Rheumatoid arthritis (RA) and osteoarthritis (OA) are characterized by inflammation, joint swelling, stiffness, and pain. A fibroid phenotype has been identified in RA, where fibrosis is the key molecular feature, and inflammation is absent. Fibroblast-like synoviocytes (FLS) are located in the synovial membrane (SM), where they produce extracellular matrix (ECM) components as a response to injury. The interplay between joint fibrosis and inflammation and its impact on ECM formation are poorly understood. We hypothesize that a fibro-inflammatory environment may affect the fibrotic response of FLS. Our objective was to characterize the fibrotic ECM profile of FLS in a fibro-inflammatory context to gain insights into the complex dynamics of fibrosis and inflammation in joint pathology.

Methods: Primary human FLS were isolated from the SM of patients undergoing total knee replacement surgery (n=8). The FLS were cultured in 0.4% fetal bovine serum DMEM with ficoll (to create a crowded environment) and ascorbic acid for 12 days. The growth factors, TGF-β1 [1 nM] and PDGF-AB [6 nM], and cytokines, IL-1β [0.5 nM] and TNF-α [0.5 nM] were added either alone or in combination. Non-treated FLS were used as control (w/o). Every 4 days, the supernatant was collected, and new treatments were added. PRO-C3, a type III collagen formation biomarker, was measured in the supernatant using a validated ELISA. 2-way ANOVA compared day-to-day differences with Tukey’s multiple comparisons tests. In addition, the AUC for each patient was computed, and the treatment differences were compared using the Kruskal-Wallis test with Dunn’s multiple comparisons tests.

Results: TGF-β increased the PRO-C3 formation from day 8 (D8) and PDGF from D4 compared to w/o (p< 0.05, Fig. 1A, 1B). Co-stimulation with TGF-β+IL-1β increased PRO-C3 on D4 compared to w/o (p< 0.05); however, it was not different from TGF-β or IL-1β alone (Fig. 1A). The AUC of co-stimulation with TGF-β+IL-1β were higher than w/o (p< 0.05, Fig. 1B). In contrast, co-stimulation with TGF-β+TNF-α increased PRO-C3 compared to w/o from D4 and onwards, and were higher than TGF-β on D4 and TNF-α on D12 (p< 0.05, Fig. 1A). The AUC of TGF-β+TNF-α was increased compared to w/o and TNF-α (p< 0.0001 and p< 0.05, respectively, Fig. 1B). Co-stimulation of PDGF+IL-1β, increased PRO-C3 from D4 and onwards compared to w/o, and to PDGF and IL-1β on D4 (p< 0.05, Fig. 1C). The AUC of the co-stimulation was increased compared with w/o (p< 0.0001, Fig. 1D). A similar trend was found for co-stimulation of PDGF+TNF-α. Here, PRO-C3 was increased on D4 and D12 compared to w/o and compared to PDGF and TNF-α on D4 (p< 0.05, Fig. 1C). The AUC of the co-stimulation was higher than w/o (p< 0.0001, Fig. 1D).

Conclusion: In conclusion, the combination of inflammatory cytokines and fibrotic growth factors induces a heightened fibrotic response, particularly increasing type III collagen formation, more than the fibrotic growth factors alone. These data suggest that the coexistence of fibrosis and inflammation could potentially influence the mechanisms driving joint damage in RA and OA. This underscores the potential need for therapeutic strategies targeting both fibrosis and inflammation in patients with arthritis.

Supporting image 1

Figure 1 The effect of fibro inflammation on type III collagen formation (PRO-C3). A) PRO-C3 increases from single stimulation of TGF-β from D8, IL_1β on D4 and TNF-α on D4 and D8 compared to w/o. Co-stimulation of TGF-β+IL_1β increases PRO-C3 on D4 compared to w/o. Co-stimulation of TGF-β+TNF-α increases PRO-C3 compared to w/o from D4 and onwards, and to TGF-β on D4 and to TNF-α on D12. B) AUC increases from stimulation of TGF-β, TGF-β+IL_1β and TGF-β+TNF-α compared to w/o. Co-stimulation of TGF-β+TNF-α also increases AUC compared to TNF-α. No. indicates the different patients. C) PDGF and PDGF+IL_1β increases PRO-C3 from D4 and onwards compared to w/o. Co-stimulation of PDGF+IL_1β also increases PRO-C3 on D4 compared to PDGF and IL_1β. Co-stimulation of PDGF+TNF-α increases PRO-C3 compared to PDGF, TNF-α and w/o on D4, and to w/o on D12. D) Co-stimulation of PDGF+IL_1β and PDGF+TNF-α increases the AUC compared to w/o. No. indicates the different patients. A significance level of p ≤ 0.05 was employed, and symbols denote the level * = p<0.05, ** =p<0.01, *** =p<0.001, **** =p<0.0001.


Disclosures: S. Madsen: None; M. Andersen: None; A. Scheller Madrid: None; S. Holm Nielsen: Nordic Bioscience, 3, 8; M. Karsdal: Nordic Bioscience, 3, 4, 8; C. Thudium: Nordic Bioscience, 3, 11; A. Bay-Jensen: Nordic Bioscience, 3, 3, 8, 9.

To cite this abstract in AMA style:

Madsen S, Andersen M, Scheller Madrid A, Holm Nielsen S, Karsdal M, Thudium C, Bay-Jensen A. Cytokines Regulate the Fibrotic Response of Growth Factors in Joint Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/cytokines-regulate-the-fibrotic-response-of-growth-factors-in-joint-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cytokines-regulate-the-fibrotic-response-of-growth-factors-in-joint-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology